Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures When Mpox Strikes the Eye: A Case for Combination Antiviral TherapyGlobal Biodefense StaffApril 16, 2026
Medical Countermeasures Smallpox Preparedness Contracts Top $60 Million as U.S. and International Partners Bolster Biodefense StockpilesGlobal Biodefense StaffMarch 25, 2026
Vaccination Programs In Schools Could Reduce Flu Cases and Deaths Medical Countermeasures June 6, 2013 …
New Kind of Antibiotic May Be More Effective Against Biothreats Antimicrobial Resistance June 5, 2013 …
Gene Therapy Gives Mice Broad Protection to Pandemic Flu Strains Medical Countermeasures June 3, 2013 …
Common Sugar Molecule Could Hold Key to Broad Spectrum Vaccine Medical Countermeasures June 3, 2013 …
Emerging H7N9 Influenza Demonstrates Antiviral Drug Resistance Medical Countermeasures May 29, 2013 …
Georgia Tech Research Suggests Drug Side Effects Are Inevitable Medical Countermeasures May 23, 2013 …
BARDA Partners with GSK for Hospital and Biothreat Antibacterials Antimicrobial Resistance May 23, 2013 …
Notable Biodefense Contracts: AnaptysBio to Develop Anti-Ricin Antibodies Industry News May 20, 2013 …
Development of In Vitro Technologies for Evaluation of CBRN Countermeasures Contracts + Grants May 20, 2013 …
NHRC, Mayo Clinic Study Immune Response Following Smallpox Vaccination Defense + Military May 17, 2013 …
